SMS Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	8,869	7,827	7,093	5,221	5,199
Other Revenue	83.54	-	-	-	-
Revenue	8,952	7,827	7,093	5,221	5,199
Revenue Growth (YoY)	14.37%	10.36%	35.86%	0.42%	-7.69%
Cost of Revenue	5,840	5,241	4,983	3,900	3,309
Gross Profit	3,112	2,587	2,109	1,321	1,890
Selling, General & Admin	879.56	828.53	658.08	547.63	515.16
Other Operating Expenses	435.91	365.67	281.41	224.85	222.38
Operating Expenses	1,715	1,538	1,255	1,094	1,059
Operating Income	1,397	1,049	854.71	226.98	830.73
Interest Expense	-230.76	-174.35	-226.18	-209.94	-181.57
Interest & Investment Income	-	6.87	7.58	7.75	5.6
Earnings From Equity Investments	139.91	17.37	6.26	-109.43	-56.61
Currency Exchange Gain (Loss)	-	50.78	28.98	39.05	25.8
Other Non Operating Income (Expenses)	-	-9.18	-4.39	-9.8	4.47
EBT Excluding Unusual Items	1,306	940.54	666.96	-55.4	628.42
Gain (Loss) on Sale of Assets	-	0.21	0.37	-0.54	-0.04
Pretax Income	1,306	940.74	667.33	-55.94	628.38
Income Tax Expense	286.4	249.39	169.07	14.65	6.18
Earnings From Continuing Operations	1,020	691.35	498.26	-70.59	622.2
Minority Interest in Earnings	-	0.01	-	-	-
Net Income	1,020	691.36	498.26	-70.59	622.2
Net Income to Common	1,020	691.36	498.26	-70.59	622.2
Net Income Growth	47.52%	38.75%	-	-	-0.49%
Shares Outstanding (Basic)	91	89	85	85	85
Shares Outstanding (Diluted)	91	89	85	85	85
Shares Change (YoY)	3.18%	4.72%	-	-	-
EPS (Basic)	11.15	7.80	5.89	-0.83	7.35
EPS (Diluted)	11.15	7.80	5.89	-0.83	7.35
EPS Growth	42.98%	32.49%	-	-	-0.49%
Free Cash Flow	-713.35	-416.71	-20.35	-74.71	178.12
Free Cash Flow Per Share	-7.80	-4.70	-0.24	-0.88	2.10
Dividend Per Share	-	0.400	0.400	0.300	0.300
Dividend Growth	-	-	33.33%	-	-
Gross Margin	34.76%	33.05%	29.74%	25.30%	36.35%
Operating Margin	15.61%	13.40%	12.05%	4.35%	15.98%
Profit Margin	11.39%	8.83%	7.03%	-1.35%	11.97%
Free Cash Flow Margin	-7.97%	-5.32%	-0.29%	-1.43%	3.43%
EBITDA	1,796	1,387	1,163	541.39	1,142
EBITDA Margin	20.07%	17.72%	16.40%	10.37%	21.97%
D&A For EBITDA	399.19	338.06	308.68	314.41	311.36
EBIT	1,397	1,049	854.71	226.98	830.73
EBIT Margin	15.61%	13.40%	12.05%	4.35%	15.98%
Effective Tax Rate	21.92%	26.51%	25.34%	-	0.98%
Revenue as Reported	8,952	7,890	7,137	5,270	5,251
Advertising Expenses	-	23.52	15.86	8.59	4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.